Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 187 of the 188 references it cites were found in a registry or an index.

Extracellular matrix-inspired biomaterials for wound healing

Open access

Abstract

Diabetic foot ulcers (DFU) are a debilitating and life-threatening complication of Diabetes Mellitus. Ulceration develops from a combination of associated diabetic complications, including neuropathy, circulatory dysfunction, and repetitive trauma, and they affect approximately 19–34% of patients as a result. The severity and chronic nature of diabetic foot ulcers stems from the disruption to normal wound healing, as a result of the molecular mechanisms which underly diabetic pathophysiology. The current standard-of-care is clinically insufficient to promote healing for many DFU patients, resulting in a high frequency of recurrence and limb amputations. Biomaterial dressings, and in particular those derived from the extracellular matrix (ECM), have emerged as a promising approach for the treatment of DFU. By providing a template for cell infiltration and skin regeneration, ECM-derived biomaterials offer great hope as a treatment for DFU. A range of approaches exist for the development of ECM-derived biomaterials, including the use of purified ECM components, decellularisation and processing of donor/ animal tissues, or the use of in vitro-deposited ECM. This review discusses the development and assessment of ECM-derived biomaterials for the treatment of chronic wounds, as well as the mechanisms of action through which ECM-derived biomaterials stimulate wound healing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11033-024-09750-9

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Disruption to the phases of wound healing in diabetic patients. The 4 phases of wound healing are negatively affected in diabetic patients. a. During Haemostasis, thickening of the blood vessel walls and reduced contractility of smooth muscle leads to perturbed vasoconstriction and reduced blood flow. Subsequent ischemia leads to insufficient platelet aggregation which prevents progression of blood coagulation after injury and delays healing. Reduced deposition of ECM at this stage also delays healing. b. The inflammatory phase is prolonged, as seen by pro-inflammatory macrophage (M1) persistence. Secretion of pro-inflammatory cytokines e.g., IL-6 and TNF-a leads to reduced phagocytosis and VEGF secretion, thus delaying angiogenesis and exacerbating local ischemia. c. As a result of insulin resistance and disrupted endothelial homeostasis in the previous phases, there is reduced nitric oxide and increased ROS production within the endothelial membrane, further preventing angiogenesis/ vasculogenesis. d. Finally, tissue remodelling is inhibited through insufficient progression of healing. Fibroblasts within a wound release excessive MMPs which are disruptive to ECM components including collagens. Similarly, exposure of the open wound to the environment increases susceptibility to serious infection during healing. Figure was created in Biorender
Fig. 1 Disruption to the phases of wound healing in diabetic patients. The 4 phases of wound healing are negatively affected in diabetic patients. a. During Haemostasis, thickening of the blood vessel walls and reduced contractility of smooth muscle leads to perturbed vasoconstriction and reduced blood flow. Subsequent ischemia leads to insufficient platelet aggregation which prevents progression of blood coagulation after injury and delays healing. Reduced deposition of ECM at this stage also delays healing. b. The inflammatory phase is prolonged, as seen by pro-inflammatory macrophage (M1) persistence. Secretion of pro-inflammatory cytokines e.g., IL-6 and TNF-a leads to reduced phagocytosis and VEGF secretion, thus delaying angiogenesis and exacerbating local ischemia. c. As a result of insulin resistance and disrupted endothelial homeostasis in the previous phases, there is reduced nitric oxide and increased ROS production within the endothelial membrane, further preventing angiogenesis/ vasculogenesis. d. Finally, tissue remodelling is inhibited through insufficient progression of healing. Fibroblasts within a wound release excessive MMPs which are disruptive to ECM components including collagens. Similarly, exposure of the open wound to the environment increases susceptibility to serious infection during healing. Figure was created in BiorenderCC BY · PubMed Central
Fig. 2 ECM-Derived Biomaterials Production and Application. There are 3 principal production methods for ECM-derived biomaterials, as discussed throughout this review. Purified ECM components, decellularised tissues, and in vitro-generated ECM are then processed to produce a biomaterial for DFU treatment. a. Purified ECM Component Biomaterials are produced from isolated ECM components including collagen, fibrin, hyaluronic acid, and elastin. ECM-derived biomaterials can be produced from single components, or from a combination of components e.g. collagen and hyaluronic acid. b. Decellularised tissue-derived ECM biomaterials are produced from animal or cadaver tissue, and decellularised to produce an acellular matrix. c. In vitro-generated biomaterials can be produced in 2 ways. Firstly, cells are kept in culture as they deposit their ECM over time. Decellularisation then removes the cellular components and preserves their ECM. Secondly, cells are seeded to a biomaterial and allowed to deposit their ECM over time, which is optimised through induction of a stimulus e.g., macromolecular crowding, ascorbic acid, increased cell density. Decellularisation then removes the cellular component, and preserves the deposited ECM, leaving an in situ deposited ECM-derived scaffold which can be implanted to an ulcer. Figure was created in Biorender
Fig. 2 ECM-Derived Biomaterials Production and Application. There are 3 principal production methods for ECM-derived biomaterials, as discussed throughout this review. Purified ECM components, decellularised tissues, and in vitro-generated ECM are then processed to produce a biomaterial for DFU treatment. a. Purified ECM Component Biomaterials are produced from isolated ECM components including collagen, fibrin, hyaluronic acid, and elastin. ECM-derived biomaterials can be produced from single components, or from a combination of components e.g. collagen and hyaluronic acid. b. Decellularised tissue-derived ECM biomaterials are produced from animal or cadaver tissue, and decellularised to produce an acellular matrix. c. In vitro-generated biomaterials can be produced in 2 ways. Firstly, cells are kept in culture as they deposit their ECM over time. Decellularisation then removes the cellular components and preserves their ECM. Secondly, cells are seeded to a biomaterial and allowed to deposit their ECM over time, which is optimised through induction of a stimulus e.g., macromolecular crowding, ascorbic acid, increased cell density. Decellularisation then removes the cellular component, and preserves the deposited ECM, leaving an in situ deposited ECM-derived scaffold which can be implanted to an ulcer. Figure was created in BiorenderCC BY · PubMed Central
Fig. 3 The mechanisms of action through which biomaterials stimulate wound healing consist of angiogenesis, immunomodulation, and antimicrobial action. Through growth factor binding, integrin and other cell-surface receptor binding, and the retention of basement membrane proteins and architecture, biomaterials stimulate angiogenesis. Through macrophage polarisation, and cellular interactions with biomaterial degradation products, biomaterials elicit immunomodulatory effects. Finally, through the inhibition of hyaluronidase, gene disruption and alteration of the bacterial cell wall net charge, biomaterials can induce wound healing through antimicrobial action. Figure was created in Biorender
Fig. 3 The mechanisms of action through which biomaterials stimulate wound healing consist of angiogenesis, immunomodulation, and antimicrobial action. Through growth factor binding, integrin and other cell-surface receptor binding, and the retention of basement membrane proteins and architecture, biomaterials stimulate angiogenesis. Through macrophage polarisation, and cellular interactions with biomaterial degradation products, biomaterials elicit immunomodulatory effects. Finally, through the inhibition of hyaluronidase, gene disruption and alteration of the bacterial cell wall net charge, biomaterials can induce wound healing through antimicrobial action. Figure was created in BiorenderCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 188 references

Research works printed but not linked: 3

  1. Packer CF, Ali SA, Manna B (2022) Diabetic Ulcer. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
  2. Magliano DJ, Boyko EJ IDF Diabetes Atlas 10th edition scientific committee (2021) IDF DIABETES ATLAS, 10th ed. International Diabetes Federation, Brussels
  3. Prohaska J, Cook C (2023) Skin grafting. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

Cited by

See all 63

Metadata

Authors
Hosty, L., Heatherington, T., Quondamatteo, F., & Browne, S.
Affiliations
Royal College of Surgeons in Ireland (IE)
Corresponding author
  • Quondamatteo, Fabio
  • Browne, Shane
Venue
Molecular Biology Reports
Published
2024-07-22
Volume
51
Issue
1
Pages
830-830
ISSN
  • 0301-4851 (ISSN-L)
  • 1573-4978
OpenAlex
W4400889181
Cited by
63
References
188
Citations by year
2026: 31 · 2025: 30 · 2024: 2
FWCI
2.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Biology Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
Royal College of Surgeons in Ireland
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
Keywords
diabetic foot ulcer, extracellular matrix, wound healing, chronic wounds, wound dressings, decellularization, skin regeneration, diabetes pathophysiology, mechanism of action
MeSH terms
Animals, Biocompatible Materials, Extracellular Matrix, Humans, Wound Healing, Diabetic Foot

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracellular matrix-inspired biomaterials for wound healing. https://app.cochat.ai/papers/10.1007/s11033-024-09750-9
The paper
Hosty, L., Heatherington, T., Quondamatteo, F., & Browne, S. (2024). Extracellular matrix-inspired biomaterials for wound healing. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09750-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.